Tworoger SS - Search Results

1

Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.

Peres LC, Townsend MK, Birmann BM, Conejo-Garcia JR, Kim Y, Kubzansky LD, Magpantay LI, Martinez-Maza O, Tworoger SS. Peres LC, et al. Among authors: tworoger ss. Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):710-718. doi: 10.1158/1055-9965.EPI-20-1390. Epub 2021 Feb 9. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33563649 Free PMC article.

2

Specimen allocation in longitudinal biomarker studies: controlling subject-specific effects by design.

Tworoger SS, Yasui Y, Chang L, Stanczyk FZ, McTiernan A. Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1257-60. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15247140 Clinical Trial.

3

Plasma prolactin concentrations and risk of postmenopausal breast cancer.

Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. Tworoger SS, et al. Cancer Res. 2004 Sep 15;64(18):6814-9. doi: 10.1158/0008-5472.CAN-04-1870. Cancer Res. 2004. PMID: 15375001

4

Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.

Tworoger SS, Sluss P, Hankinson SE. Tworoger SS, et al. Cancer Res. 2006 Feb 15;66(4):2476-82. doi: 10.1158/0008-5472.CAN-05-3369. Cancer Res. 2006. PMID: 16489055

5

Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer.

Tworoger SS, Hecht JL, Giovannucci E, Hankinson SE. Tworoger SS, et al. Am J Epidemiol. 2006 Jun 15;163(12):1101-11. doi: 10.1093/aje/kwj128. Epub 2006 Mar 22. Am J Epidemiol. 2006. PMID: 16554344

6

Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?

Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE. Eliassen AH, et al. Among authors: tworoger ss. J Clin Oncol. 2006 Apr 20;24(12):1823-30. doi: 10.1200/JCO.2005.03.7432. Epub 2006 Mar 27. J Clin Oncol. 2006. PMID: 16567770

7

The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.

Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE. Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):967-71. doi: 10.1158/1055-9965.EPI-05-0976. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16702378

8

A prospective study of postmenopausal hormone use and ovarian cancer risk.

Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE. Danforth KN, et al. Among authors: tworoger ss. Br J Cancer. 2007 Jan 15;96(1):151-6. doi: 10.1038/sj.bjc.6603527. Epub 2006 Dec 19. Br J Cancer. 2007. PMID: 17179984 Free PMC article.

9

Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.

Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE. Eliassen AH, et al. Among authors: tworoger ss. Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):161-4. doi: 10.1158/1055-9965.EPI-06-0693. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17220346

10

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. Tworoger SS, et al. J Clin Oncol. 2007 Apr 20;25(12):1482-8. doi: 10.1200/JCO.2006.07.6356. Epub 2007 Mar 19. J Clin Oncol. 2007. PMID: 17372279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters